Rousseau A - Search Results

1

In vitro and in vivo study of the antithyroid side effects of trimeprazine.

Sauvage MF, Rousseau A, Marquet P, Dumeirain F, Raby C, Lachâtre G. Sauvage MF, et al. Among authors: rousseau a. Toxicol Appl Pharmacol. 1999 Jul 15;158(2):125-31. doi: 10.1006/taap.1999.8699. Toxicol Appl Pharmacol. 1999. PMID: 10406927

2

Relationship between psychotropic drugs and thyroid function: a review.

Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachâtre G. Sauvage MF, et al. Among authors: rousseau a. Toxicol Appl Pharmacol. 1998 Apr;149(2):127-35. doi: 10.1006/taap.1998.8367. Toxicol Appl Pharmacol. 1998. PMID: 9571980 Review.

3

Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration.

Rousseau A, Marquet P, Lagorce JF, Sauvage MF, Buxeraud J, Lachâtre G, Raby C. Rousseau A, et al. Pharmacology. 1998 Nov;57(5):242-8. doi: 10.1159/000028248. Pharmacology. 1998. PMID: 9742289

4

An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.

Prémaud A, Rousseau A, Gicquel M, Ragot S, Manceau J, Laurentie M, Marquet P. Prémaud A, et al. Among authors: rousseau a. Toxicol Appl Pharmacol. 2002 Sep 15;183(3):189-97. doi: 10.1006/taap.2002.9467. Toxicol Appl Pharmacol. 2002. PMID: 12383710

5

Synthesis and antithyroid activity of pyridine, pyrimidine and pyrazine derivatives of thiazole-2-thiol and 2-thiazoline-2-thiol.

Lagorce JF, Comby F, Rousseau A, Buxeraud J, Raby C. Lagorce JF, et al. Among authors: rousseau a. Chem Pharm Bull (Tokyo). 1993 Jul;41(7):1258-60. doi: 10.1248/cpb.41.1258. Chem Pharm Bull (Tokyo). 1993. PMID: 7690688

6

Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.

Rousseau A, Marquet P, Comby F, Buxeraud J, Raby C, Lachâtre G. Rousseau A, et al. J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):93-100. doi: 10.1016/s0378-4347(97)00052-2. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9200522

7

Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.

Rousseau A, Marquet P. Rousseau A, et al. Fundam Clin Pharmacol. 2002 Aug;16(4):253-62. doi: 10.1046/j.1472-8206.2002.00086.x. Fundam Clin Pharmacol. 2002. PMID: 12570013 Review.

8

Modelling ciclosporin double-peak absorption profiles in the early post-transplantation period.

Rousseau A, Marquet P. Rousseau A, et al. Clin Pharmacokinet. 2004;43(14):1055-7. doi: 10.2165/00003088-200443140-00007. Clin Pharmacokinet. 2004. PMID: 15530133

9

Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.

Prémaud A, Rousseau A, Le Meur Y, Lachâtre G, Marquet P. Prémaud A, et al. Among authors: rousseau a. Ther Drug Monit. 2004 Dec;26(6):609-19. doi: 10.1097/00007691-200412000-00005. Ther Drug Monit. 2004. PMID: 15570184

10

Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions.

Marquet P, Sauvage FL, Loustaud-Ratti V, Babany G, Rousseau A, Lachâtre G. Marquet P, et al. Among authors: rousseau a. Ther Drug Monit. 2010 Apr;32(2):237-41. doi: 10.1097/FTD.0b013e3181d3f686. Ther Drug Monit. 2010. PMID: 20216114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters